{"id":"https://openalex.org/W3019764296","doi":"https://doi.org/10.1016/j.drudis.2020.04.012","title":"Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations","display_name":"Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations","publication_year":2020,"publication_date":"2020-04-27","ids":{"openalex":"https://openalex.org/W3019764296","doi":"https://doi.org/10.1016/j.drudis.2020.04.012","mag":"3019764296","pmid":"https://pubmed.ncbi.nlm.nih.gov/32344040"},"language":"en","primary_location":{"id":"doi:10.1016/j.drudis.2020.04.012","doi":"https://doi.org/10.1016/j.drudis.2020.04.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.drudis.2020.04.012","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359644620301604/pdf","source":{"id":"https://openalex.org/S152068293","display_name":"Drug Discovery Today","issn_l":"1359-6446","issn":["1359-6446","1878-5832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery Today","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S1359644620301604/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026358497","display_name":"Rick A. Vreman","orcid":"https://orcid.org/0000-0002-2076-322X","observed_orcids":["https://orcid.org/0000-0002-2076-322X"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210126763","display_name":"Zorginstituut Nederland","ror":"https://ror.org/038b4c997","country_code":"NL","type":"government","lineage":["https://openalex.org/I4210126763"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rick A. Vreman","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands; The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands","Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands","The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands; The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands","institution_ids":["https://openalex.org/I193662353","https://openalex.org/I4210126763"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands","institution_ids":["https://openalex.org/I4210126763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037592549","display_name":"Angela S. de Ruijter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Angela S. de Ruijter","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005605741","display_name":"Anna Zawada","orcid":"https://orcid.org/0000-0002-3555-4877","observed_orcids":["https://orcid.org/0000-0002-3555-4877"]},"institutions":[{"id":"https://openalex.org/I268303160","display_name":"Medical University of Warsaw","ror":"https://ror.org/04p2y4s44","country_code":"PL","type":"education","lineage":["https://openalex.org/I268303160"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anna Zawada","raw_affiliation_strings":["Medical University of Warsaw, Zwirki i Wigury St. 61, 02-091 Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Warsaw, Zwirki i Wigury St. 61, 02-091 Warsaw, Poland","institution_ids":["https://openalex.org/I268303160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007531158","display_name":"Giovanni Tafuri","orcid":"https://orcid.org/0000-0002-9283-0153","observed_orcids":["https://orcid.org/0000-0002-9283-0153"]},"institutions":[{"id":"https://openalex.org/I4210126763","display_name":"Zorginstituut Nederland","ror":"https://ror.org/038b4c997","country_code":"NL","type":"government","lineage":["https://openalex.org/I4210126763"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Giovanni Tafuri","raw_affiliation_strings":["The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands","institution_ids":["https://openalex.org/I4210126763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012178128","display_name":"Violeta V. Stoyanova-Beninska","orcid":"https://orcid.org/0000-0002-7521-165X","observed_orcids":["https://orcid.org/0000-0002-7521-165X"]},"institutions":[{"id":"https://openalex.org/I1297934274","display_name":"European Medicines Agency","ror":"https://ror.org/01z0wsw92","country_code":"NL","type":"government","lineage":["https://openalex.org/I1297934274","https://openalex.org/I1320481043"]},{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Violeta Stoyanova-Beninska","raw_affiliation_strings":["Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands; College ter Beoordeling van Geneesmiddelen/Medicines Evaluation Board (CBG-MEB), Graadt van Roggenweg 500, 3531 AH, Utrecht, The Netherlands","College ter Beoordeling van Geneesmiddelen/Medicines Evaluation Board (CBG-MEB), Graadt van Roggenweg 500, 3531 AH, Utrecht, The Netherlands","Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands; College ter Beoordeling van Geneesmiddelen/Medicines Evaluation Board (CBG-MEB), Graadt van Roggenweg 500, 3531 AH, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I1297934274","https://openalex.org/I4210150351"]},{"raw_affiliation_string":"College ter Beoordeling van Geneesmiddelen/Medicines Evaluation Board (CBG-MEB), Graadt van Roggenweg 500, 3531 AH, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]},{"raw_affiliation_string":"Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I1297934274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040482265","display_name":"Daniel J O\u2019Connor","orcid":"https://orcid.org/0000-0001-7378-1125","observed_orcids":["https://orcid.org/0000-0001-7378-1125"]},"institutions":[{"id":"https://openalex.org/I1297934274","display_name":"European Medicines Agency","ror":"https://ror.org/01z0wsw92","country_code":"NL","type":"government","lineage":["https://openalex.org/I1297934274","https://openalex.org/I1320481043"]},{"id":"https://openalex.org/I4405282191","display_name":"Medicines and Healthcare products Regulatory Agency","ror":"https://ror.org/05fan1e59","country_code":"GB","type":"government","lineage":["https://openalex.org/I4405282191"]}],"countries":["GB","NL"],"is_corresponding":false,"raw_author_name":"Daniel O\u2019Connor","raw_affiliation_strings":["Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands","Medicines and Healthcare products Regulatory Agency (MHRA), 10 SC, Canary Wharf, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I1297934274"]},{"raw_affiliation_string":"Medicines and Healthcare products Regulatory Agency (MHRA), 10 SC, Canary Wharf, London, UK","institution_ids":["https://openalex.org/I4405282191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086606252","display_name":"Frauke Naumann\u2010Winter","orcid":"https://orcid.org/0000-0003-0913-1157","observed_orcids":["https://orcid.org/0000-0003-0913-1157"]},"institutions":[{"id":"https://openalex.org/I123859907","display_name":"Federal Institute for Drugs and Medical Devices","ror":"https://ror.org/05ex5vz81","country_code":"DE","type":"government","lineage":["https://openalex.org/I123859907"]},{"id":"https://openalex.org/I1297934274","display_name":"European Medicines Agency","ror":"https://ror.org/01z0wsw92","country_code":"NL","type":"government","lineage":["https://openalex.org/I1297934274","https://openalex.org/I1320481043"]}],"countries":["DE","NL"],"is_corresponding":false,"raw_author_name":"Frauke Naumann-Winter","raw_affiliation_strings":["Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands; Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany","Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany","Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands; Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany","institution_ids":["https://openalex.org/I123859907","https://openalex.org/I1297934274"]},{"raw_affiliation_string":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany","institution_ids":["https://openalex.org/I123859907"]},{"raw_affiliation_string":"Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I1297934274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038816973","display_name":"F Wolter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123859907","display_name":"Federal Institute for Drugs and Medical Devices","ror":"https://ror.org/05ex5vz81","country_code":"DE","type":"government","lineage":["https://openalex.org/I123859907"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Franziska Wolter","raw_affiliation_strings":["Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Germany","institution_ids":["https://openalex.org/I123859907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041722553","display_name":"Aukje Kaija Mantel-Teeuwisse","orcid":"https://orcid.org/0000-0002-8782-0698","observed_orcids":["https://orcid.org/0000-0002-8782-0698"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Aukje K. Mantel-Teeuwisse","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035747289","display_name":"Hubert G. M. Leufkens","orcid":"https://orcid.org/0000-0002-7175-1499","observed_orcids":["https://orcid.org/0000-0002-7175-1499"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hubert G.M. Leufkens","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090685830","display_name":"Iordanis Sidiropoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297934274","display_name":"European Medicines Agency","ror":"https://ror.org/01z0wsw92","country_code":"NL","type":"government","lineage":["https://openalex.org/I1297934274","https://openalex.org/I1320481043"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Iordanis Sidiropoulos","raw_affiliation_strings":["Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I1297934274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085418811","display_name":"Kristina Larsson","orcid":"https://orcid.org/0000-0003-4361-6502","observed_orcids":["https://orcid.org/0000-0003-4361-6502"]},"institutions":[{"id":"https://openalex.org/I1297934274","display_name":"European Medicines Agency","ror":"https://ror.org/01z0wsw92","country_code":"NL","type":"government","lineage":["https://openalex.org/I1297934274","https://openalex.org/I1320481043"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Kristina Larsson","raw_affiliation_strings":["Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Committee for Orphan Medicinal Products, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I1297934274"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022725827","display_name":"Wim Goettsch","orcid":"https://orcid.org/0000-0002-8022-7496","observed_orcids":["https://orcid.org/0000-0002-8022-7496"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210126763","display_name":"Zorginstituut Nederland","ror":"https://ror.org/038b4c997","country_code":"NL","type":"government","lineage":["https://openalex.org/I4210126763"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Wim G. Goettsch","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands; The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands. Electronic address: w.g.goettsch@uu.nl","Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands","The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands; The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands. Electronic address: w.g.goettsch@uu.nl","institution_ids":["https://openalex.org/I193662353","https://openalex.org/I4210126763"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"The National Health Care Institute (ZIN), Willem Dudokhof 1, 1112 ZA Diemen, The Netherlands","institution_ids":["https://openalex.org/I4210126763"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5022725827"],"corresponding_institution_ids":["https://openalex.org/I193662353","https://openalex.org/I4210126763"],"apc_list":{"value":4250,"currency":"USD","value_usd":4250},"apc_paid":{"value":4250,"currency":"USD","value_usd":4250},"fwci":0.6293,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.71014493,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"25","issue":"7","first_page":"1223","last_page":"1231"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5659000277519226,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5659000277519226,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.3917999863624573,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drugs","display_name":"orphan drugs","score":0.9940000176429749},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.9739999771118164},{"id":"https://openalex.org/keywords/european-medicines-agency","display_name":"European Medicines Agency","score":0.8840000033378601},{"id":"https://openalex.org/keywords/orphan-drug-designation","display_name":"orphan drug designation","score":0.7129999995231628},{"id":"https://openalex.org/keywords/regulatory-assessment","display_name":"regulatory evaluation","score":0.44200000166893005},{"id":"https://openalex.org/keywords/clinical-evidence","display_name":"clinical evidence","score":0.6449999809265137},{"id":"https://openalex.org/keywords/patient-populations","display_name":"patient populations","score":0.6420000195503235},{"id":"https://openalex.org/keywords/comparator","display_name":"comparator","score":0.8669999837875366},{"id":"https://openalex.org/keywords/outcome-measures","display_name":"outcome measures","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.934907078742981},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.7583173513412476},{"id":"https://openalex.org/C21333345","wikidata":"https://www.wikidata.org/wiki/Q1519843","display_name":"Health technology","level":3,"score":0.6864843964576721},{"id":"https://openalex.org/C3019398576","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory agency","level":2,"score":0.6549511551856995},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.5866236686706543},{"id":"https://openalex.org/C2777589142","wikidata":"https://www.wikidata.org/wiki/Q6770899","display_name":"Marketing authorization","level":2,"score":0.5016365051269531},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4893602728843689},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4233478903770447},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4114052653312683},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3658756613731384},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33723360300064087},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.2771845757961273},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.25611603260040283},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.15671709179878235},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.13658800721168518},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.12371394038200378},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.09972333908081055},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09720370173454285},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.08883744478225708},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C3116431","wikidata":"https://www.wikidata.org/wiki/Q31728","display_name":"Public administration","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D013673","descriptor_name":"Technology Assessment, Biomedical","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.drudis.2020.04.012","doi":"https://doi.org/10.1016/j.drudis.2020.04.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.drudis.2020.04.012","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359644620301604/pdf","source":{"id":"https://openalex.org/S152068293","display_name":"Drug Discovery Today","issn_l":"1359-6446","issn":["1359-6446","1878-5832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery Today","raw_type":"journal-article"},{"id":"pmid:32344040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32344040","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug discovery today","raw_type":"Journal Article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/410895","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/410895","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/410895","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/410895","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Discovery Today, 25(7), 1223. Elsevier Ltd","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.drudis.2020.04.012","doi":"https://doi.org/10.1016/j.drudis.2020.04.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.drudis.2020.04.012","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1359644620301604/pdf","source":{"id":"https://openalex.org/S152068293","display_name":"Drug Discovery Today","issn_l":"1359-6446","issn":["1359-6446","1878-5832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Discovery Today","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3019764296.pdf","grobid_xml":"https://content.openalex.org/works/W3019764296.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W132296830","https://openalex.org/W1456616809","https://openalex.org/W1572319397","https://openalex.org/W1598602811","https://openalex.org/W1657561747","https://openalex.org/W1708016541","https://openalex.org/W1973663806","https://openalex.org/W2054519060","https://openalex.org/W2085841923","https://openalex.org/W2096145249","https://openalex.org/W2104263006","https://openalex.org/W2144253786","https://openalex.org/W2212454316","https://openalex.org/W2298950253","https://openalex.org/W2320603831","https://openalex.org/W2471940171","https://openalex.org/W2564509916","https://openalex.org/W2599639624","https://openalex.org/W2761623236","https://openalex.org/W2790385930","https://openalex.org/W2895742152","https://openalex.org/W2897458944","https://openalex.org/W2901295411","https://openalex.org/W2901313771","https://openalex.org/W2947019202","https://openalex.org/W4229850741"],"related_works":["https://openalex.org/W2906485318","https://openalex.org/W4311351370","https://openalex.org/W2130643721","https://openalex.org/W3039685384","https://openalex.org/W4404977533","https://openalex.org/W3113011395","https://openalex.org/W2766430698","https://openalex.org/W3111509209","https://openalex.org/W4283065690","https://openalex.org/W2766231777"],"abstract_inverted_index":{"To":[0],"maintain":[1],"orphan":[2,11],"drug":[3],"status":[4],"at":[5],"the":[6,26,34,46,58,63,71],"time":[7],"of":[8,33],"market":[9],"authorization,":[10],"medicinal":[12],"products":[13],"(OMPs)":[14],"need":[15],"to":[16],"be":[17],"assessed":[18],"for":[19,28,66,74,96,105],"all":[20,97],"criteria,":[21],"including":[22,70],"significant":[23],"benefit,":[24],"by":[25],"Committee":[27],"Orphan":[29],"Medicinal":[30],"Products":[31],"(COMP)":[32],"European":[35,72],"Medicines":[36],"Agency":[37],"(EMA).":[38],"Subsequently,":[39],"health":[40],"technology":[41],"assessment":[42,81],"(HTA)":[43],"organizations":[44],"evaluate":[45],"same":[47],"OMPs":[48],"in":[49],"their":[50],"relative":[51],"effectiveness":[52],"assessments":[53],"(REAs).":[54],"This":[55],"review":[56],"investigates":[57],"similarities":[59],"and":[60,93],"differences":[61,78],"between":[62,79],"two":[64],"frameworks":[65,82],"six":[67],"HTA":[68],"organizations,":[69],"Network":[73],"HTA.":[75],"We":[76],"discuss":[77],"both":[80],"within":[83],"five":[84],"domains":[85],"(clinical":[86],"evidence":[87],"used,":[88],"patient":[89],"population,":[90],"intervention,":[91],"comparators,":[92],"outcome":[94],"measures)":[95],"drugs.":[98],"Five":[99],"illustrative":[100],"cases":[101],"studies":[102],"were":[103],"selected":[104],"a":[106],"qualitative":[107],"review.":[108]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-05-01T00:00:00"}